Zealand Pharma A-S Aktie

57,26 EUR +1,64 EUR +2,95 %

11:10:21

STU

52,96 CHF +0,21 CHF +0,39 %

17:23:43

BRX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.4,02 Mrd. EUR

Div. Rendite0,00%

WKNA0YJW7

ISINDK0060257814

SymbolZLDPF

Zealand Pharma A-S Aktien News

Sortieren:Datum Meistgelesen

31.03.24GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at March 31, 2024

26.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

26.03.24GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

21.03.24GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments

20.03.24GlobeNewswireZealand Pharma's Annual General Meeting 2024

19.03.24GlobeNewswireZealand Pharma major shareholder announcement: Polar Capital

19.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

13.03.24GlobeNewswireNew Employee Elected Directors to the Board of Zealand Pharma A/S

08.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

05.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

05.03.24GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

27.02.24GlobeNewswireZealand Pharma convenes its Annual General Meeting 2024

27.02.24GlobeNewswireZealand Pharma Announces Financial Results for the Full Year 2023

26.02.24GlobeNewswireZealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibro

31.01.24GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at January 31, 2024

26.01.24GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments

19.01.24GlobeNewswireZealand Pharma major shareholder announcement: J O Hambro Capital Management

17.01.24GlobeNewswireZealand Pharma major shareholder announcement: J O Hambro Capital Management

12.01.24GlobeNewswireZealand Pharma completes registration of capital increase

10.01.24GlobeNewswireZealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

08.01.24GlobeNewswireZealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion

29.12.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at December 29, 2023

23.12.23GlobeNewswireU.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing

07.12.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

07.12.23GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

04.12.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

30.11.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at November 30, 2023

30.11.23GlobeNewswireZealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers

16.11.23GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

09.11.23GlobeNewswireZealand Pharma Announces Financial Results for the First Nine Months of 2023

20.10.23GlobeNewswireZealand Pharma major shareholder announcement: Polar Capital

29.09.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at September 29, 2023

14.09.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

14.09.23GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

31.08.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

31.08.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at August 31, 2023

30.08.23GlobeNewswireZealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

25.08.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

24.08.23GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

17.08.23GlobeNewswireZealand Pharma Announces Financial Results for the First Half of 2023

Zealand Pharma A-S News

Zealand Pharma A-S News: auf dieser Seite finden Sie alle Zealand Pharma A-S News und Nachrichten zur Zealand Pharma A-S Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Zealand Pharma A-S News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Zealand Pharma A-S News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.